| Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non–small cell lung cancer by quantitative real-time RT-PCR A Markou, EG Tsaroucha, L Kaklamanis, M Fotinou, V Georgoulias, ... Clinical chemistry 54 (10), 1696-1704, 2008 | 532 | 2008 |
| Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients N Xenidis, M Perraki, M Kafousi, S Apostolaki, I Bolonaki, A Stathopoulou, ... J Clin Oncol 24 (23), 3756-3762, 2006 | 342 | 2006 |
| Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges ES Lianidou, A Markou Clinical chemistry 57 (9), 1242-1255, 2011 | 335 | 2011 |
| Different prognostic value of cytokeratin-19 mRNA–positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer M Ignatiadis, N Xenidis, M Perraki, S Apostolaki, E Politaki, M Kafousi, ... Journal of clinical oncology 25 (33), 5194-5202, 2007 | 304 | 2007 |
| Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer N Xenidis, M Ignatiadis, S Apostolaki, M Perraki, K Kalbakis, S Agelaki, ... J Clin Oncol 27 (13), 2177-2184, 2009 | 300 | 2009 |
| Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early … M Ignatiadis, G Kallergi, M Ntoulia, M Perraki, S Apostolaki, M Kafousi, ... Clinical Cancer Research 14 (9), 2593-2600, 2008 | 293 | 2008 |
| Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis FC Tsz-fung, YM Youssef, E Lianidou, AD Romaschin, RJ Honey, ... Clinical biochemistry 43 (1-2), 150-158, 2010 | 261 | 2010 |
| Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability IS Sourvinou, A Markou, ES Lianidou The Journal of Molecular Diagnostics 15 (6), 827-834, 2013 | 232 | 2013 |
| Clinical evaluation of microRNA expression profiling in non small cell lung cancer A Markou, I Sourvinou, PA Vorkas, GM Yousef, E Lianidou Lung cancer 81 (3), 388-396, 2013 | 225 | 2013 |
| Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system A Stathopoulou, A Gizi, M Perraki, S Apostolaki, N Malamos, D Mavroudis, ... Clinical Cancer Research 9 (14), 5145-5151, 2003 | 202 | 2003 |
| Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma A Strati, G Koutsodontis, G Papaxoinis, I Angelidis, M Zavridou, ... Annals of Oncology 28 (8), 1923-1933, 2017 | 187 | 2017 |
| Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell G Sotiropoulou, G Pampalakis, E Lianidou, Z Mourelatos Rna 15 (8), 1443-1461, 2009 | 183 | 2009 |
| DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells M Chimonidou, A Strati, A Tzitzira, G Sotiropoulou, N Malamos, ... Clinical chemistry 57 (8), 1169-1177, 2011 | 181 | 2011 |
| Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics C Kroupis, A Markou, N Vourlidis, A Dionyssiou-Asteriou, ES Lianidou Clinical biochemistry 39 (7), 727-731, 2006 | 167 | 2006 |
| SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer M Chimonidou, A Strati, N Malamos, V Georgoulias, ES Lianidou Clinical chemistry 59 (1), 270-279, 2013 | 164 | 2013 |
| Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay A Markou, A Strati, N Malamos, V Georgoulias, ES Lianidou Clinical chemistry 57 (3), 421-430, 2011 | 163 | 2011 |
| Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients G Kallergi, H Markomanolaki, V Giannoukaraki, MA Papadaki, A Strati, ... Breast Cancer Research 11, 1-12, 2009 | 157 | 2009 |
| Liquid biopsies E Lianidou, K Pantel Genes, Chromosomes and Cancer 58 (4), 219-232, 2019 | 154 | 2019 |
| Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA–positive tumor cells in the peripheral blood and bone marrow of patients … V Bozionellou, D Mavroudis, M Perraki, S Papadopoulos, S Apostolaki, ... Clinical Cancer Research 10 (24), 8185-8194, 2004 | 152 | 2004 |
| Circulating tumor cells as promising novel biomarkers in solid cancers ES Lianidou, A Strati, A Markou Critical reviews in clinical laboratory sciences 51 (3), 160-171, 2014 | 147 | 2014 |
Areti StratiPostdoctoral ResearcherVerified email at chem.uoa.gr
